Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Putamen haemorrhage
ADR ID BADD_A08394
ADR Hierarchy
17      Nervous system disorders
17.08      Central nervous system vascular disorders
17.08.01      Central nervous system haemorrhages and cerebrovascular accidents
17.08.01.058      Putamen haemorrhage
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.04      Nervous system haemorrhagic disorders
24.07.04.031      Putamen haemorrhage
Description Intracranial bleeding into the PUTAMEN, a BASAL GANGLIA nucleus. This is associated with HYPERTENSION and lipohyalinosis of small blood vessels in the putamen. Clinical manifestations vary with the size of hemorrhage, but include HEMIPARESIS; HEADACHE; and alterations of consciousness. | A collection of blood in PUTAMEN. [MeSH]
MedDRA Code 10058940
MeSH ID D020146
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Putamen haemorrhage | Putamen hemorrhage | Putamen bleeding | Putaminal Hemorrhage | Hemorrhage, Putaminal | Hemorrhage, Putamen | Putamen Hemorrhage | Brain Hemorrhage, Putaminal | Brain Hemorrhages, Putaminal | Putaminal Hematoma
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000265%
BADD_D00869Famotidine0.000068%
BADD_D01245Lansoprazole0.000419%
BADD_D01954Rivaroxaban0.000372%
BADD_D02100Sunitinib0.000533%
The 1th Page    1    Total 1 Pages